Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1

Status

Completed 11Unknown 4Terminated 2Active not recruiting 2Recruiting 1Not yet recruiting 1

Sponsor Class

INDUSTRY 4OTHER 2NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Genitourinary 1

Conditions

Urinary Bladder Neoplasms 1Side Effect of Drug 1

Interventions

pembrolizumab 223Cyclophosphamide 192Radiotherapy 183Nivolumab 181Carboplatin 153Cisplatin 114Paclitaxel 112Dexamethasone 110Radiosurgery 103Magnetic Resonance Spectroscopy 97Surveys and Questionnaires 90Ipilimumab 81Doxorubicin 79Lenalidomide 76Rituximab 75durvalumab 74atezolizumab 72Radiation 72fludarabine 68Standard of Care 68Gemcitabine 68venetoclax 67Specimen Handling 65Etoposide 64Capecitabine 64Bevacizumab 62Oxaliplatin 59Docetaxel 58Biopsy 58Radiotherapy, Intensity-Modulated 56

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Active not recruiting × OTHER × BCG Vaccine × Clear all
NCT04701151 2026-03-03

NORTH-REG Dwell-Time Study

Aarhus University Hospital

Phase 4 Active not recruiting
314 enrolled

Side Effect of Drug

NCT03799835 2024-12-11

ALBAN

UNICANCER

Phase 3 Active not recruiting
517 enrolled
Genitourinary

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡